
The rising risks towards human health are pushing the research and innovations in the genomic market, opening multi-faceted opportunities for the market. Also, the rapid adoption of technological advancements is increasingly accelerating its potential to cater to patients.
Against this backdrop, it could be wise to invest in fundamentally strong genomic research stocks Agilent Technologies, Inc. (A), Illumina, Inc. (ILMN), and 10x Genomics, Inc. (TXG) with significant growth potential.